Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.105 USD | -3.91% | -10.57% | -11.29% |
May. 09 | Transcript : Akebia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.29% | 241M | |
+7.68% | 115B | |
+12.74% | 107B | |
-13.29% | 22.31B | |
-3.99% | 21.6B | |
-6.39% | 18.23B | |
-39.93% | 17.62B | |
+6.80% | 14.26B | |
+32.71% | 12.37B | |
-28.68% | 8.28B |
- Stock Market
- Equities
- AKBA Stock
- News Akebia Therapeutics, Inc.
- Piper Sandler Upgrades Akebia Therapeutics to Overweight From Neutral, Adjusts Price Target to $4 From $2